Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

PubMed

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.

PMID : 31116032 ·

P, h, i, l, i, p, , U, r, b, a, n, ;, , R, o, x, a, n, a, , M, e, h, r, a, n, ;, , R, o, i, s, i, n, , C, o, l, l, e, r, a, n, ;, , D, o, m, i, n, i, c, k, , J, , A, n, g, i, o, l, i, l, l, o, ;, , R, o, b, e, r, t, , A, , B, y, r, n, e, ;, , D, a, v, i, d, e, , C, a, p, o, d, a, n, n, o, ;, , T, h, o, m, a, s, , C, u, i, s, s, e, t, ;, , D, o, n, a, l, d, , C, u, t, l, i, p, ;, , P, e, d, r, o, , E, e, r, d, m, a, n, s, ;, , J, o, h, n, , E, i, k, e, l, b, o, o, m, ;, , A, n, d, r, e, w, , F, a, r, b, ;, , C, , M, i, c, h, a, e, l, , G, i, b, s, o, n, ;, , J, o, h, n, , G, r, e, g, s, o, n, ;, , M, i, c, h, a, e, l, , H, a, u, d, e, ;, , S, t, e, f, a, n, , K, , J, a, m, e, s, ;, , H, y, o, -, S, o, o, , K, i, m, ;, , T, a, k, e, s, h, i, , K, i, m, u, r, a, ;, , A, k, i, h, i, d, e, , K, o, n, i, s, h, i, ;, , J, o, h, n, , L, a, s, c, h, i, n, g, e, r, ;, , M, a, r, t, i, n, , B, , L, e, o, n, ;, , P, , F, , A, d, r, i, a, n, , M, a, g, e, e, ;, , Y, o, s, h, i, a, k, i, , M, i, t, s, u, t, a, k, e, ;, , D, a, r, r, e, n, , M, y, l, o, t, t, e, ;, , S, t, u, a, r, t, , P, o, c, o, c, k, ;, , M, a, t, t, h, e, w, , J, , P, r, i, c, e, ;, , S, u, n, i, l, , V, , R, a, o, ;, , E, r, n, e, s, t, , S, p, i, t, z, e, r, ;, , N, o, r, m, a, n, , S, t, o, c, k, b, r, i, d, g, e, ;, , M, a, r, c, o, , V, a, l, g, i, m, i, g, l, i, ;, , O, l, i, v, i, e, r, , V, a, r, e, n, n, e, ;, , U, t, e, , W, i, n, d, h, o, e, v, e, l, ;, , R, o, b, e, r, t, , W, , Y, e, h, ;, , M, i, t, c, h, e, l, l, , W, , K, r, u, c, o, f, f, ;, , M, a, r, i, e, -, C, l, a, u, d, e, , M, o, r, i, c, e

RevueCirculation
Année
PMID31116032

Résumé

Identification and management of patients at high bleeding risk undergoing percutaneous coronary intervention are of major importance, but a lack of standardization in defining this population limits trial design, data interpretation, and clinical decision-making. The Academic Research Consortium for High Bleeding Risk (ARC-HBR) is a collaboration among leading research organizations, regulatory authorities, and physician-scientists from the United States, Asia, and Europe focusing on percutaneo

Source officielle

Voir sur PubMed →

Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.

↑